
@article{ref1,
title="A man committed suicide",
journal="Journal of Acute Medicine",
year="2022",
author="Lee, Ching-Hsing",
volume="12",
number="4",
pages="161-162",
abstract="<p>A 58-year-old male presented to the emergen- cy department (ED) with nausea and vomiting one hour after committing suicide by ingestion of arsenic trioxide. Vital signs in triage revealed a respiratory rate of 22 breaths per minute, heart rate of 100 beats per minute, and blood pressure of 99/51 mmHg. The physical examination showed clear consciousness and soft abdomen without tenderness nor rebound pain. The laboratory evaluation disclosed elevated blood creatinine 1.4 mg/dL (normal: 0.64–1.27 mg/ dL) and alanine transaminase 103 U/L (normal: < 36 U/L). The other basic biochemistry blood examina- tions were unremarkable. The chest X-ray revealed hyperdense lesion in the left upper quadrant of abdo- men (Fig. 1, arrowheads). Nasogastric tube irrigation was performed for decontamination. Intravenous 2,3-dimercapto-1-propanesulfonic acid (DMPS) was prescribed. Acute kidney injury, metabolic acidosis, acute respiratory failure, and shock occurred 6 hours after ingestion. His clinical condition deteriorated de- spite fluid resuscitation and inotropic agents use. The patient deceased 11 hours after ingestion. Blood arse- nic ultimately revealed 730 μg/L (normal: < 20 μg/L).  Discussion The initial presentation of acute arsenic intox- ication includes nausea, vomiting, diarrhea, and ab- dominal pain, followed by renal failure, respiratory failure, and shock.1 These symptoms and signs are non-specific. Hence, there is no specific toxidrome for clinical diagnosis.</p> <p>Language: en</p>",
language="en",
issn="2211-5587",
doi="10.6705/j.jacme.202212_12(4).0005",
url="http://dx.doi.org/10.6705/j.jacme.202212_12(4).0005"
}